CoChat

The NLRP3 Inflammasome as a Critical Actor in the Inflammaging Process

Sebastian-Valverde, Maria, Pasinetti, Giulio M. · 2020 · Cells
Cited by 83

The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.

Abstract

As a consequence of the considerable increase in the human lifespan over the last century, we are experiencing the appearance and impact of new age-related diseases. The causal relationships between aging and an enhanced susceptibility of suffering from a broad spectrum of diseases need to be better understood. However, one specific shared feature seems to be of capital relevance for most of these conditions: the low-grade chronic inflammatory state inherently associated with aging, i.e., inflammaging. Here, we review the molecular and cellular mechanisms that link aging and inflammaging, focusing on the role of the innate immunity and more concretely on the nucleotide-binding oligomerization domain (NOD)-like receptor family pyrin domain containing 3 (NLRP3) inflammasome, as well as how the chronic activation of this inflammasome has a detrimental effect on different age-related disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells9061552

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 99 references

Research works printed but not linked: 179

  1. Bonilla, 2010, Adaptive immunity, J. Allergy Clin. Immunol., 125, S33, 10.1016/j.jaci.2009.09.017 · DOI · Paper page
  2. Hernandez, 2010, Age-related deregulation of naive T cell homeostasis in elderly humans, AGE, 33, 197
  3. Weng, 2006, Aging of the Immune System: How Much Can the Adaptive Immune System Adapt?, Immunity, 24, 495, 10.1016/j.immuni.2006.05.001 · DOI · Paper page
  4. Medzhitov, 2000, Innate Immunity, N. Engl. J. Med., 343, 338, 10.1056/NEJM200008033430506 · DOI · Paper page
  5. Mortensen, 2001, C-Reactive Protein, Inflammation, and Innate Immunity, Immunol. Res., 24, 163, 10.1385/IR:24:2:163 · DOI · Paper page
  6. Summers, 2010, Neutrophil kinetics in health and disease, Trends Immunol., 31, 318, 10.1016/j.it.2010.05.006 · DOI · Paper page
  7. Tortorella, 1999, Age-related effects of oxidative metabolism and cyclic AMP signaling on neutrophil apoptosis, Mech. Ageing Dev., 110, 195, 10.1016/S0047-6374(99)00055-X · DOI
  8. Larbi, 2004, Signal transduction and functional changes in neutrophils with aging, Aging Cell, 3, 217, 10.1111/j.1474-9728.2004.00110.x · DOI · Paper page
  9. Ito, 1998, Impaired glutathione peroxidase activity accounts for the age-related accumulation of hydrogen peroxide in activated human neutrophils, J. Gerontol. Ser. A Biol. Sci. Med Sci., 53, M169, 10.1093/gerona/53A.3.M169 · DOI
  10. Wenisch, 2000, Effect of age on human neutrophil function, J. Leukoc. Biol., 67, 40, 10.1002/jlb.67.1.40 · DOI · Paper page
  11. Steinman, 2006, Dendritic cells: Translating innate to adaptive immunity, Current Topics in Microbiology and Immunology, 311, 17
  12. Pawelec, 2013, Immunosenescence in vertebrates and invertebrates, Immun. Ageing, 10, 12, 10.1186/1742-4933-10-12 · DOI · Paper page
  13. Corberand, 1981, Polymorphonuclear Functions and Aging in Humans, J. Am. Geriatr. Soc., 29, 391, 10.1111/j.1532-5415.1981.tb02376.x · DOI · Paper page
  14. Wu, 2001, Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoantigens: Implications for systemic autoimmunity, Arthritis Rheum., 44, 2642, 10.1002/1529-0131(200111)44:11<2642::AID-ART444>3.0.CO;2-8 · DOI · Paper page
  15. Locati, 2013, Macrophage Activation and Polarization as an Adaptive Component of Innate Immunity, Advances in Immunology, 120, 163, 10.1016/B978-0-12-417028-5.00006-5 · DOI · Paper page
  16. Bowdish, 2007, Macrophage receptors implicated in the “adaptive” form of innate immunity, Microbes Infect., 9, 1680, 10.1016/j.micinf.2007.09.002 · DOI
  17. Keller, 1993, The macrophage response to infectious agents: Mechanisms of macrophage activation and tumour cell killing, Res. Immunol., 144, 271, 10.1016/0923-2494(93)80105-8 · DOI
  18. Lloberas, J., Tur, J., Vico, T., and Celada, A. (2019). Molecular and Cellular Aspects of Macrophage Aging. Handbook of Immunosenescence, Springer Science and Business Media LLC. · DOI
  19. Takahashi, 2015, Attenuated phagocytosis of secondary necrotic neutrophils by macrophages in aged and SMP30 knockout mice, Geriatr. Gerontol. Int., 16, 135, 10.1111/ggi.12436 · DOI
  20. Solana, 1991, Cell mediated immunity in ageing, Comp. Biochem. Physiol. Part A Physiol., 99, 1, 10.1016/0300-9629(91)90224-Z · DOI
  21. Herrero, 2001, IFN-γ–dependent transcription of MHC class II IA is impaired in macrophages from aged mice, J. Clin. Investig., 107, 485, 10.1172/JCI11696 · DOI · Paper page
  22. Cao, 2005, Aging Increases Stromal/Osteoblastic Cell-Induced Osteoclastogenesis and Alters the Osteoclast Precursor Pool in the Mouse, J. Bone Miner. Res., 20, 1659, 10.1359/JBMR.050503 · DOI · Paper page
  23. Frei, 1987, Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells, Eur. J. Immunol., 17, 1271, 10.1002/eji.1830170909 · DOI · Paper page
  24. Shrikant, 1996, The central nervous system as an immunocompetent organ: Role of glial cells in antigen presentation, J. Immunol., 157, 157, 10.4049/jimmunol.157.5.1819 · DOI · Paper page
  25. Floden, 2011, Microglia Demonstrate Age-Dependent Interaction with Amyloid-β Fibrils, JAD, 25, 279, 10.3233/JAD-2011-101014 · DOI · Paper page
  26. Touil, 2015, Roles of microglia in brain development, tissue maintenance and repair, Brain, 138, 1138, 10.1093/brain/awv066 · DOI · Paper page
  27. Roubenoff, 2003, Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: The Framingham Heart Study, Am. J. Med., 115, 429, 10.1016/j.amjmed.2003.05.001 · DOI · Paper page
  28. Pawelec, 2014, Inflammation, ageing and chronic disease, Curr. Opin. Immunol., 29, 23, 10.1016/j.coi.2014.03.007 · DOI · Paper page
  29. Guo, 2015, Inflammasomes: Mechanism of action, role in disease, and therapeutics, Nat. Med., 21, 677, 10.1038/nm.3893 · DOI · Paper page
  30. Platnich, 2019, NOD-like receptors and inflammasomes: A review of their canonical and non-canonical signaling pathways, Arch. Biochem. Biophys., 670, 4, 10.1016/j.abb.2019.02.008 · DOI · Paper page
  31. Liu, 2014, The role of inflammasome in Alzheimer’s disease, Ageing Res. Rev., 15, 6, 10.1016/j.arr.2013.12.007 · DOI · Paper page
  32. Soares, 2019, Variants in NLRP3 and NLRC4 inflammasome associate with susceptibility and severity of multiple sclerosis, Mult. Scler. Relat. Disord., 29, 26, 10.1016/j.msard.2019.01.023 · DOI · Paper page
  33. Aganna, 2002, Association of mutations in theNALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis, Arthritis Rheum., 46, 2445, 10.1002/art.10509 · DOI · Paper page
  34. Yin, 2017, NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer’s Disease, Mol. Neurobiol., 55, 1977, 10.1007/s12035-017-0467-9 · DOI · Paper page
  35. Piva, 2006, NF-κB: A Stress-Regulated Switch for Cell Survival, Antioxid. Redox Signal., 8, 478, 10.1089/ars.2006.8.478 · DOI · Paper page
  36. Hayflick, 1961, The serial cultivation of human diploid cell strains, Exp. Cell Res., 25, 585, 10.1016/0014-4827(61)90192-6 · DOI · Paper page
  37. Brummel, 2004, Immunity and aging: The enemy within?, Aging Cell, 3, 195, 10.1111/j.1474-9728.2004.00106.x · DOI · Paper page
  38. Li, 2012, Age-related changes in CD8 T cell homeostasis and immunity to infection, Semin. Immunol., 24, 356, 10.1016/j.smim.2012.04.009 · DOI · Paper page
  39. Sidler, C., Woycicki, R., Ilnytskyy, Y., Metz, G.A.S., Kovalchuk, I., and Kovalchuk, O. (2013). Immunosenescence is associated with altered gene expression and epigenetic regulation in primary and secondary immune organs. Front. Genet., 4. · DOI · Paper page
  40. Malaquin, N., Carrier-Leclerc, A., Dessureault, M., and Rodier, F. (2015). DDR-mediated crosstalk between DNA-damaged cells and their microenvironment. Front. Genet., 6. · DOI · Paper page
  41. Xu, 2006, DNA damage: A trigger of innate immunity but a requirement for adaptive immune homeostasis, Nat. Rev. Immunol., 6, 261, 10.1038/nri1804 · DOI
  42. Liu, 1996, Three distinct signalling responses by murine fibroblasts to genotoxic stress, Nature, 384, 273, 10.1038/384273a0 · DOI · Paper page
  43. Gonzalez, 2008, NKG2D ligands: Key targets of the immune response, Trends Immunol., 29, 397, 10.1016/j.it.2008.04.007 · DOI · Paper page
  44. Frontini, 2009, A ChIP-chip approach reveals a novel role for transcription factor IRF1 in the DNA damage response, Nucleic Acids Res., 37, 1073, 10.1093/nar/gkn1051 · DOI
  45. Hayden, 2008, Shared Principles in NF-κB Signaling, Cell, 132, 344, 10.1016/j.cell.2008.01.020 · DOI · Paper page
  46. Bonafe, 2011, Inflamm-aging of the stem cell niche: Breast cancer as a paradigmatic example, Bioessays, 34, 40, 10.1002/bies.201100104 · DOI · Paper page
  47. Karakasilioti, 2013, DNA damage triggers a chronic autoinflammatory response, leading to fat depletion in NER progeria, Cell Metab., 18, 403, 10.1016/j.cmet.2013.08.011 · DOI · Paper page
  48. Pateras, 2015, The DNA damage response and immune signaling alliance: Is it good or bad? Nature decides when and where, Pharmacol. Ther., 154, 36, 10.1016/j.pharmthera.2015.06.011 · DOI
  49. Mena, 2015, Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders, Mitochondrion, 21, 92, 10.1016/j.mito.2015.02.001 · DOI · Paper page
  50. Napier, 2005, Iron trafficking in the mitochondrion: Novel pathways revealed by disease, Blood, 105, 1867, 10.1182/blood-2004-10-3856 · DOI · Paper page
  51. Rossier, 2006, T channels and steroid biosynthesis: In search of a link with mitochondria, Cell Calcium, 40, 155, 10.1016/j.ceca.2006.04.020 · DOI
  52. das, 2006, Mitochondrial calcium signalling and cell death: Approaches for assessing the role of mitochondrial Ca2+ uptake in apoptosis, Cell Calcium, 40, 553, 10.1016/j.ceca.2006.08.016 · DOI · Paper page
  53. Santulli, 2015, Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging, Curr. Mol. Pharmacol., 8, 206, 10.2174/1874467208666150507105105 · DOI · Paper page
  54. Harman, 1956, Aging: A Theory Based on Free Radical and Radiation Chemistry, J. Gerontol., 11, 298, 10.1093/geronj/11.3.298 · DOI · Paper page
  55. Larsson, 2010, Somatic Mitochondrial DNA Mutations in Mammalian Aging, Annu. Rev. Biochem., 79, 683, 10.1146/annurev-biochem-060408-093701 · DOI · Paper page
  56. Newgard, 2014, Recent progress in metabolic signaling pathways regulating aging and life span, J. Gerontol. Ser. A Biol. Sci. Med Sci., 69, S21, 10.1093/gerona/glu058 · DOI · Paper page
  57. Zamzami, 1997, Mitochondrial implication in accidental and programmed cell death: Apoptosis and necrosis, J. Bioenerg. Biomembr., 29, 185, 10.1023/A:1022694131572 · DOI · Paper page
  58. Shintani, 2013, TLR9 mediates cellular protection by modulating energy metabolism in cardiomyocytes and neurons, Proc. Natl. Acad. Sci USA, 110, 5109, 10.1073/pnas.1219243110 · DOI · Paper page
  59. Subramanian, 2013, The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation, Cell, 153, 348, 10.1016/j.cell.2013.02.054 · DOI · Paper page
  60. Ravikumar, 2010, Regulation of Mammalian Autophagy in Physiology and Pathophysiology, Physiol. Rev., 90, 1383, 10.1152/physrev.00030.2009 · DOI · Paper page
  61. Choi, 2011, Autophagy in Inflammatory Diseases, Int. J. Cell Biol., 2011, 1, 10.1155/2011/732798 · DOI · Paper page
  62. Yang, 2016, Autophagy Inhibition Dysregulates TBK1 Signaling and Promotes Pancreatic Inflammation, Cancer Immunol. Res., 4, 520, 10.1158/2326-6066.CIR-15-0235 · DOI · Paper page
  63. Liu, 2019, Regulation of Inflammasome by Autophagy, Advances in Experimental Medicine and Biology, 1209, 109, 10.1007/978-981-15-0606-2_7 · DOI
  64. Kee, 2019, Genetic polymorphisms of ATG16L1 and IRGM genes in Malaysian patients with Crohn’s disease, J. Dig. Dis., 21, 29, 10.1111/1751-2980.12829 · DOI
  65. Hsieh, 2011, Complete Induction of Autophagy Is Essential for Cardioprotection in Sepsis, Ann. Surg., 253, 1190, 10.1097/SLA.0b013e318214b67e · DOI · Paper page
  66. Pantano, 2006, Redox-Sensitive Kinases of the Nuclear Factor-κB Signaling Pathway, Antioxid. Redox Signal., 8, 1791, 10.1089/ars.2006.8.1791 · DOI · Paper page
  67. Ko, 2017, Rapamycin regulates macrophage activation by inhibiting NLRP3 inflammasome-p38 MAPK-NFκB pathways in autophagy- and p62-dependent manners, Oncotarget, 8, 40817, 10.18632/oncotarget.17256 · DOI · Paper page
  68. Niida, 2010, Downregulation of active IKKβ by Ro52-mediated autophagy, Mol. Immunol., 47, 2378, 10.1016/j.molimm.2010.05.004 · DOI · Paper page
  69. Hanahan, 2011, Hallmarks of Cancer: The Next Generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
  70. Sosa, 2013, Oxidative stress and cancer: An overview, Ageing Res. Rev., 12, 376, 10.1016/j.arr.2012.10.004 · DOI · Paper page
  71. Saha, S.K., Bin-Lee, S., Won, J., Choi, H.Y., Kim, K., Yang, G.-M., Dayem, A.A., and Cho, S.-G. (2017). Correlation between Oxidative Stress, Nutrition, and Cancer Initiation. Int. J. Mol. Sci., 18. · DOI · Paper page
  72. Kamp, 2011, Chronic inflammation, and cancer: The role of the mitochondria, Oncol., 25, 400
  73. Moloney, 2018, ROS signalling in the biology of cancer, Semin. Cell Dev. Biol., 80, 50, 10.1016/j.semcdb.2017.05.023 · DOI · Paper page
  74. Kim, M.K., and Song, Y.S. (2014). Stress Response, Inflammaging, and Cancer. Inflammation, Advancing Age and Nutrition, Elsevier BV. · DOI
  75. Ronchetti, 2014, Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth, Oncogene, 34, 3493
  76. Civenni, G., Shinde, D., Zoma, M., Albino, D., Costales, P., Moris, F., Carbone, G., and Catapano, C. (2017). The multi-kinase inhibitor EC-70124 delivers a double-hit to prostate cancer stem cells interfering with both STAT3 and NF-kB signaling. Eur. Urol. Suppl., 16. · doi:10.1016/s1569-9056(17)30803-5
  77. Kreuz, 2001, NF-κB Inducers Upregulate cFLIP, a Cycloheximide-Sensitive Inhibitor of Death Receptor Signaling, Mol. Cell. Biol., 21, 3964, 10.1128/MCB.21.12.3964-3973.2001 · DOI · Paper page
  78. Irmler, 1997, Inhibition of death receptor signals by cellular FLIP, Nature, 388, 190, 10.1038/40657 · DOI · Paper page
  79. Bullani, 2001, Selective Expression of FLIP in Malignant Melanocytic Skin Lesions, J. Investig. Dermatol., 117, 360, 10.1046/j.0022-202x.2001.01418.x · DOI
  80. Humphreys, 2018, FLIP as a therapeutic target in cancer, FEBS J., 285, 4104, 10.1111/febs.14523 · DOI
  81. Lee, 1999, Role of Bcl-2 family proteins (Bax, Bcl-2 and Bcl-X) on cellular susceptibility to radiation in pancreatic cancer cells, Eur. J. Cancer, 35, 1374, 10.1016/S0959-8049(99)00134-3 · DOI
  82. Campbell, 2018, Targeting BCL-2 regulated apoptosis in cancer, Open Biol., 8, 180002, 10.1098/rsob.180002 · DOI · Paper page
  83. Pierce, 1994, Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors, Mol. Cell. Biol., 14, 1039
  84. Guttridge, 1999, NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1, Mol. Cell. Biol., 19, 5785, 10.1128/MCB.19.8.5785 · DOI · Paper page
  85. Chen, 2001, New Insights into the Role of Nuclear Factor-κB in Cell Growth Regulation, Am. J. Pathol., 159, 387, 10.1016/S0002-9440(10)61708-7 · DOI · Paper page
  86. Biliran, 2007, c-Myc Induced Chemosensitization Is Mediated by Suppression of Cyclin D1 Expression and Nuclear Factor—B Activity in Pancreatic Cancer Cells, Clin. Cancer Res., 13, 2811, 10.1158/1078-0432.CCR-06-1844 · doi:10.1158/1078-0432.ccr-06-1844
  87. Dahlman, 2009, The RelA/p65 subunit of NF-κB specifically regulates cyclin D1 protein stability: Implications for cell cycle withdrawal and skeletal myogenesis, J. Cell. Biochem., 106, 42, 10.1002/jcb.21976 · DOI
  88. Lang, 2019, NF-κB signaling and crosstalk during carcinogenesis, 4open, 2, 13, 10.1051/fopen/2019010 · DOI
  89. Furth, 2013, STAT signaling in different breast cancer sub-types, Mol. Cell. Endocrinol., 382, 612, 10.1016/j.mce.2013.03.023 · DOI
  90. Avalle, 2017, STAT3 in cancer: A double edged sword, Cytokine, 98, 42, 10.1016/j.cyto.2017.03.018 · DOI
  91. Reed, 1999, Mechanisms of apoptosis avoidance in cancer, Curr. Opin. Oncol., 11, 68, 10.1097/00001622-199901000-00014 · DOI · Paper page
  92. Clohessy, 2005, Mcl-1 Interacts with Truncated Bid, and Inhibits Its Induction of Cytochromec Release and Its Role in Receptor-mediated Apoptosis, J. Biol. Chem., 281, 5750, 10.1074/jbc.M505688200 · DOI · Paper page
  93. Welcker, 1996, Enhanced protein stability: A novel mechanism of D-type cyclin over-abundance identified in human sarcoma cells, Oncogene, 13, 419
  94. Wei, 2003, Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis, Oncogene, 22, 319, 10.1038/sj.onc.1206122 · DOI · Paper page
  95. Dechow, 2004, Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C, Proc. Natl. Acad. Sci. USA, 101, 10602, 10.1073/pnas.0404100101 · DOI · Paper page
  96. Petrilli, 2015, Abstract 2038: A novel role for the NLRP3 inflammasome in lung cancer, Mol. Cellul. Biol., 75, 2038
  97. Pontillo, 2016, Role of inflammasome genetics in susceptibility to HPV infection and cervical cancer development, J. Med Virol., 88, 1646, 10.1002/jmv.24514 · DOI
  98. Ahmad, 2013, Thymoquinone suppresses metastasis of melanoma cells by inhibition of NLRP3 inflammasome, Toxicol. Appl. Pharmacol., 270, 70, 10.1016/j.taap.2013.03.027 · DOI
  99. Latz, 2018, NLRP3 inflammasome activation in inflammaging, Semin. Immunol., 40, 61, 10.1016/j.smim.2018.09.001 · DOI · Paper page
  100. Hotamisligil, 1993, Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance, Science, 259, 87, 10.1126/science.7678183 · DOI · Paper page
  101. Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J. Clin. Investig., 112, 1796, 10.1172/JCI200319246 · DOI · Paper page
  102. Mohammadi, 2017, Clinical Significance of Serum IL-6 and TNF-α Levels in Patients with Metabolic Syndrome, Rep. Biochem. Mol. Biol., 6, 74
  103. Reddy, 2014, Epigenetic mechanisms in diabetic complications and metabolic memory, Diabetologia, 58, 443, 10.1007/s00125-014-3462-y · DOI · Paper page
  104. Hotamisligil, 2006, Inflammation and metabolic disorders, Nature, 444, 860, 10.1038/nature05485 · DOI · Paper page
  105. Leong, 2016, Type 2 Diabetes Genetic Predisposition, Obesity, and All-Cause Mortality Risk in the U.S.: A Multiethnic Analysis, Diabetes Care, 39, 539, 10.2337/dc15-2080 · DOI
  106. Kahn, 1988, The insulin receptor and the molecular mechanism of insulin action, J. Clin. Investig., 82, 1151, 10.1172/JCI113711 · DOI · Paper page
  107. Schalkwijk, 2013, Obesity-associated low-grade inflammation in type 2 diabetes mellitus: Causes and consequences, Neth. J. Med., 71, 174
  108. Ehses, 2007, Increased Number of Islet-Associated Macrophages in Type 2 Diabetes, Diabetes, 56, 2356, 10.2337/db06-1650 · DOI · Paper page
  109. Moon, 2015, mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation, Cell Rep., 12, 102, 10.1016/j.celrep.2015.05.046 · DOI · Paper page
  110. Xie, 2016, PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation, Nat. Commun., 7, 13280, 10.1038/ncomms13280 · DOI · Paper page
  111. Paneni, 2014, Molecular mechanisms of vascular dysfunction and cardiovascular biomarkers in type 2 diabetes, Cardiovasc. Diagn. Ther., 4, 324
  112. Prattichizzo, 2015, Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes, Clin. Epigenetics, 7, 56, 10.1186/s13148-015-0090-4 · DOI · Paper page
  113. Bonfigli, 2016, Leukocyte telomere length and mortality risk in patients with type 2 diabetes, Oncotarget, 7, 50835, 10.18632/oncotarget.10615 · DOI
  114. Shalev, 2002, Oligonucleotide Microarray Analysis of Intact Human Pancreatic Islets: Identification of Glucose-Responsive Genes and a Highly Regulated TGFβ Signaling Pathway, Endocrinology, 143, 3695, 10.1210/en.2002-220564 · DOI · Paper page
  115. Kwon, H., and Pessin, J.E. (2013). Adipokines Mediate Inflammation and Insulin Resistance. Front. Endocrinol., 4. · DOI · Paper page
  116. Yiannikouris, 2010, Adipokines, and blood pressure control, Curr. Opin. Nephrol. Hypertens., 19, 195, 10.1097/MNH.0b013e3283366cd0 · DOI · Paper page
  117. Yadav, 2013, Role of leptin and adiponectin in insulin resistance, Clin. Chim. Acta, 417, 80, 10.1016/j.cca.2012.12.007 · DOI · Paper page
  118. Jager, 2006, Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression, Endocrinology, 148, 241, 10.1210/en.2006-0692 · DOI · Paper page
  119. Wen, 2011, Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling, Nat. Immunol., 12, 408, 10.1038/ni.2022 · DOI · Paper page
  120. Grant, R.W., and Dixit, V.D. (2013). Mechanisms of disease: Inflammasome activation and the development of type 2 diabetes. Front. Immunol., 4. · DOI · Paper page
  121. Wolf, 2001, Differential expression of costimulatory molecules B7-1 and B7-2 on microglial cells induced by Th1 and Th2 cells in organotypic brain tissue, Glia, 36, 414, 10.1002/glia.1127 · DOI · Paper page
  122. Lane, 2017, Alzheimer’s disease, Eur. J. Neurol., 25, 59, 10.1111/ene.13439 · DOI · Paper page
  123. Luchsinger, 2009, Adiposity, Type 2 Diabetes, and Alzheimer’s Disease, JAD, 16, 693, 10.3233/JAD-2009-1022 · DOI · Paper page
  124. Mendelsohn, 2013, Sleep Facilitates Clearance of Metabolites from the Brain: Glymphatic Function in Aging and Neurodegenerative Diseases, Rejuvenat. Res., 16, 518, 10.1089/rej.2013.1530 · DOI · Paper page
  125. Blasko, 2000, The amyloid β peptide Aβ (25-35) induces apoptosis independent of p53, FEBS Lett., 470, 221, 10.1016/S0014-5793(00)01323-5 · DOI · Paper page
  126. Mudher, 2002, Alzheimer’s disease—Do tauists and baptists finally shake hands?, Trends Neurosci., 25, 22, 10.1016/S0166-2236(00)02031-2 · DOI · Paper page
  127. Giacomazza, 2012, Alzheimer’s disease: Biological aspects, therapeutic perspectives, and diagnostic tools, J. Physics Condens. Matter, 24, 244102, 10.1088/0953-8984/24/24/244102 · DOI
  128. Liu, 2018, Role of ROS and Nutritional Antioxidants in Human Diseases, Front. Physiol., 9, 477, 10.3389/fphys.2018.00477 · DOI · Paper page
  129. Ando, 2010, N-cadherin Regulates p38 MAPK Signaling via Association with JNK-associated Leucine Zipper Protein, J. Biol. Chem., 286, 7619, 10.1074/jbc.M110.158477 · DOI · Paper page
  130. Bisht, 2018, Chronic stress as a risk factor for Alzheimer’s disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress, Neurobiol. Stress, 9, 9, 10.1016/j.ynstr.2018.05.003 · DOI · Paper page
  131. Gutierrez, E.R., Muñoz-Arenas, G., Treviño, S., Espinosa, B., Chavez, R., Rojas, K., Flores, G., Diaz, A., and Guevara, J. (2017). Alzheimer’s disease and metabolic syndrome: A link from oxidative stress and inflammation to neurodegeneration. Synapse, 71. · DOI · Paper page
  132. Lian, 2018, Cathepsin B-Mediated NLRP3 Inflammasome Formation and Activation in Angiotensin II -Induced Hypertensive Mice: Role of Macrophage Digestion Dysfunction, Cell. Physiol. Biochem., 50, 1585, 10.1159/000494656 · DOI
  133. Heid, 2013, Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation, J. Immunol., 191, 5230, 10.4049/jimmunol.1301490 · DOI · Paper page
  134. Hornung, 2010, Critical functions of priming and lysosomal damage for NLRP3 activation, Eur. J. Immunol., 40, 620, 10.1002/eji.200940185 · DOI · Paper page
  135. Stutz, 2013, ASC Speck Formation as a Readout for Inflammasome Activation, Advanced Structural Safety Studies, 1040, 91
  136. Kalia, 2015, Parkinson’s disease, Lancet, 386, 896, 10.1016/S0140-6736(14)61393-3 · DOI · Paper page
  137. Tysnes, 2017, Epidemiology of Parkinson’s disease, J. Neural Transm., 124, 901, 10.1007/s00702-017-1686-y · DOI · Paper page
  138. Braak, 2003, Staging of brain pathology related to sporadic Parkinson’s disease, Neurobiol. Aging, 24, 197, 10.1016/S0197-4580(02)00065-9 · DOI · Paper page
  139. Kluss, 2019, LRRK2 links genetic and sporadic Parkinson’s disease, Biochem. Soc. Trans., 47, 651, 10.1042/BST20180462 · DOI · Paper page
  140. Haque, 2019, Targeting the Microglial NLRP3 Inflammasome and Its Role in Parkinson’s Disease, Mov. Disord., 35, 20, 10.1002/mds.27874 · DOI · Paper page
  141. Kim, 2016, Mitophagy: A balance regulator of NLRP3 inflammasome activation, BMB Rep., 49, 529, 10.5483/BMBRep.2016.49.10.115 · DOI · Paper page
  142. Luo, 2015, Mitochondria: A Therapeutic Target for Parkinson’s Disease?, Int. J. Mol. Sci., 16, 20704, 10.3390/ijms160920704 · DOI · Paper page
  143. Tschopp, 2010, NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?, Nat. Rev. Immunol., 10, 210, 10.1038/nri2725 · DOI · Paper page
  144. Abais, 2015, Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?, Antioxid. Redox Signal., 22, 1111, 10.1089/ars.2014.5994 · DOI · Paper page
  145. Zecca, 2001, Substantia nigra neuromelanin: Structure, synthesis, and molecular behaviour, Mol. Pathol., 54, 414
  146. Laguna, 2019, Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis, Nat. Commun., 10, 973, 10.1038/s41467-019-08858-y · DOI · Paper page
  147. Pinho, 2018, Mitochondrial superoxide generation induces a parkinsonian phenotype in zebrafish and huntingtin aggregation in human cells, Free. Radic. Biol. Med., 130, 318, 10.1016/j.freeradbiomed.2018.10.446 · DOI
  148. Raza, 2019, Parkinson’s disease: Mechanisms, translational models, and management strategies, Life Sci., 226, 77, 10.1016/j.lfs.2019.03.057 · DOI · Paper page
  149. Lin, 2006, Mitochondrial dysfunction, and oxidative stress in neurodegenerative diseases, Nature, 443, 787, 10.1038/nature05292 · DOI · Paper page
  150. Jellinger, 2011, Neuropathology of sporadic Parkinson’s disease: Evaluation and changes of concepts, Mov. Disord., 27, 8, 10.1002/mds.23795 · DOI · Paper page
  151. Rocha, 2015, Insights into Neuroinflammation in Parkinson’s Disease: From Biomarkers to Anti-Inflammatory Based Therapies, BioMed Res. Int., 2015, 1
  152. Beraud, D., Twomey, M., Bloom, B., Mittereder, A., Ton, V., Neitzke, K., Chasovskikh, S., Mhyre, T.R., and Maguire-Zeiss, K. (2011). α-Synuclein Alters Toll-Like Receptor Expression. Front. Mol. Neurosci., 5. · DOI · Paper page
  153. Li, 2019, Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution, Sci. Rep., 9, 1734, 10.1038/s41598-018-37584-6 · DOI · Paper page
  154. Riggs, 1982, Changes in Bone Mineral Density of the Proximal Femur and Spine with Aging, J. Clin. Investig., 70, 716, 10.1172/JCI110667 · DOI · Paper page
  155. Greco, 2019, Osteoporosis and Sarcopenia Increase Frailty Syndrome in the Elderly, Front. Endocrinol., 10, 255, 10.3389/fendo.2019.00255 · DOI · Paper page
  156. 2013, Recent Advances: Osteoporosis in the “Oldest Old”, Curr. Osteoporos. Rep., 11, 270, 10.1007/s11914-013-0158-z · DOI
  157. Al-Saedi, A., Stupka, N., and Duque, G. (2020). Pathogenesis of Osteoporosis. Drug Delivery, Springer Science and Business Media LLC. · DOI
  158. Udagawa, 2003, The mechanism of osteoclast differentiation from macrophages: Possible roles of T lymphocytes in osteoclastogenesis, J. Bone Miner. Metab., 21, 337, 10.1007/s00774-003-0439-1 · DOI
  159. Park, 2017, Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation, Mol. Cells, 40, 706, 10.14348/molcells.2017.0225 · DOI · Paper page
  160. Hill, 2006, Arthropathy of neonatal onset multisystem inflammatory disease (NOMID/CINCA), Pediatr. Radiol., 37, 145, 10.1007/s00247-006-0358-0 · DOI
  161. Bonar, S.L., Brydges, S.D., Mueller, J.L., McGeough, M.D., Pena, C., Chen, D., Grimston, S.K., Hickman-Brecks, C.L., Ravindran, S., and McAlinden, A. (2012). Constitutively Activated NLRP3 Inflammasome Causes Inflammation and Abnormal Skeletal Development in Mice. PLoS ONE, 7. · DOI · Paper page
  162. Miller, 2011, Preservation of femoral bone thickness in middle age predicts survival in genetically heterogeneous mice, Aging Cell, 10, 383, 10.1111/j.1474-9726.2011.00671.x · DOI
  163. Van de Sande, M.G.H., de Hair, M.J.H., Schuller, Y., van de Sande, G.P.M., Wijbrandts, C.A., Dinant, H.J., Gerlag, D.M., and Tak, P.-P. (2012). The Features of the Synovium in Early Rheumatoid Arthritis According to the 2010 ACR/EULAR Classification Criteria. PLoS ONE, 7. · DOI
  164. Nalbant, S., and Birlik, A.M. (2017). Cytokines in Rheumatoid Arthritis (RA). New Developments in the Pathogenesis of Rheumatoid Arthritis, IntechOpen. · DOI
  165. Noack, 2017, Selected cytokine pathways in rheumatoid arthritis, Semin. Immunopathol., 39, 365, 10.1007/s00281-017-0619-z · DOI · Paper page
  166. Mathews, 2013, Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment, Ann. Rheum. Dis., 73, 1202, 10.1136/annrheumdis-2013-203276 · DOI · Paper page
  167. Choulaki, 2015, Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis, Arthritis Res., 17, 257, 10.1186/s13075-015-0775-2 · DOI · Paper page
  168. Xie, 2017, MicroRNA-33 regulates the NLRP3 inflammasome signaling pathway in macrophages, Mol. Med. Rep., 17, 3318
  169. Ruscitti, 2015, Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: A pos, Clin. Exp. Immunol., 182, 35, 10.1111/cei.12667 · DOI · Paper page
  170. Kolly, 2010, Expression and function of the NALP3 inflammasome in rheumatoid synovium, Immunology, 129, 178, 10.1111/j.1365-2567.2009.03174.x · DOI · Paper page
  171. Radstake, 2003, Association of interleukin-18 expression with enhanced levels of both interleukin-1? And tumor necrosis factor? In knee synovial tissue of patients with rheumatoid arthritis, Arthritis Rheum., 48, 339, 10.1002/art.10814 · DOI · Paper page
  172. Cai, 2014, Association of IL-18 promoter gene polymorphisms with rheumatoid arthritis: A meta-analysis, Mol. Biol. Rep., 41, 8211, 10.1007/s11033-014-3723-3 · doi:10.1007/s11033-014-3723-3
  173. Chalan, 2015, Rheumatoid Arthritis, Immunosenescence and the Hallmarks of Aging, Curr. Aging Sci., 8, 131, 10.2174/1874609808666150727110744 · DOI · Paper page
  174. Bruijn, R.F.A.G.D., and Ikram, M.A. (2014). Cardiovascular risk factors and future risk of Alzheimer’s disease. BMC Med., 12. · DOI · Paper page
  175. Dhingra, 2011, Age as a Risk Factor, Med Clin. North Am., 96, 87, 10.1016/j.mcna.2011.11.003 · DOI · Paper page
  176. Moslehi, 2012, Telomeres and mitochondria in the aging heart, Circ. Res., 110, 1226, 10.1161/CIRCRESAHA.111.246868 · DOI · Paper page
  177. Sasaki, 2017, The Impact of Autophagy on Cardiovascular Senescence and Diseases, Int. Hear. J., 58, 666, 10.1536/ihj.17-246 · DOI · Paper page
  178. Pirillo, A., Norata, G.D., and Catapano, A.L. (2013). LOX-1, OxLDL, and Atherosclerosis. Mediat. Inflamm., 1–12. · DOI · Paper page
  179. Garcia, K.C., Llanas-Cornejo, D., and Husi, H. (2017). CVD and Oxidative Stress. J. Clin. Med., 6. · DOI · Paper page

Cited by

Metadata

Authors
Sebastian-Valverde, M., & Pasinetti, G. M.
Affiliations
Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Venue
Cells
Publisher
MDPI AG
Published
2020-06-26
Volume
9
Issue
6
Pages
1552
ISSN
2073-4409
Cited by
83
References
99
Language
en
Funders
National Center for Complementary and Integrative Health (P50 AT008661-01)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.